India’s Vaccine Approvals Had One Problem. It Gave Rise To the Other Two.
Bharat Biotech chairman and MD Krishna Ella (right) and Serum Institute CEO Adar Poonawalla. Photos: Twitter and PTI.
For all the Narendra Modi government’s desire to push an Indian company to the forefront of the national COVID-19 response, it has actually put an Indian company in an awkward, even untenable, position.
